SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $31,650,000 | +7.7% | 3,000,000 | -14.3% | 4.86% | -3.2% |
| Q4 2016 | $29,400,000 | +17.3% | 3,500,000 | 0.0% | 5.03% | +84.2% |
| Q3 2016 | $25,060,000 | -6.9% | 3,500,000 | 0.0% | 2.73% | -9.0% |
| Q2 2016 | $26,915,000 | +5.2% | 3,500,000 | 0.0% | 3.00% | +8.3% |
| Q1 2016 | $25,585,000 | -5.2% | 3,500,000 | 0.0% | 2.77% | +3.1% |
| Q4 2015 | $26,985,000 | +25.8% | 3,500,000 | +16.7% | 2.69% | +43.6% |
| Q3 2015 | $21,450,000 | -32.7% | 3,000,000 | 0.0% | 1.87% | -18.7% |
| Q2 2015 | $31,860,000 | -14.2% | 3,000,000 | 0.0% | 2.30% | -18.1% |
| Q1 2015 | $37,140,000 | +32.7% | 3,000,000 | 0.0% | 2.81% | +49.4% |
| Q4 2014 | $27,990,000 | -6.9% | 3,000,000 | 0.0% | 1.88% | -17.9% |
| Q3 2014 | $30,060,000 | -2.9% | 3,000,000 | 0.0% | 2.29% | +5.8% |
| Q2 2014 | $30,960,000 | +1.1% | 3,000,000 | +21.9% | 2.16% | -16.1% |
| Q1 2014 | $30,631,000 | +6.0% | 2,460,300 | +4.7% | 2.58% | +1.9% |
| Q4 2013 | $28,905,000 | +56.0% | 2,350,000 | +9.3% | 2.53% | +30.2% |
| Q3 2013 | $18,533,000 | +42.0% | 2,150,000 | +43.3% | 1.94% | -15.9% |
| Q2 2013 | $13,050,000 | – | 1,500,000 | – | 2.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DRILL CRAIG A | 1,700,000 | $12,172,000 | 49.92% |
| NORTH TIDE CAPITAL, LLC | 3,500,000 | $25,060,000 | 2.73% |
| Senvest Management, LLC | 3,843,251 | $27,518,000 | 1.97% |
| PERRITT CAPITAL MANAGEMENT INC | 424,570 | $3,040,000 | 0.76% |
| Camber Capital Management LP | 2,347,593 | $16,809,000 | 0.74% |
| DALTON GREINER HARTMAN MAHER & CO | 1,550,006 | $11,098,000 | 0.72% |
| Profit Investment Management, LLC | 88,777 | $636,000 | 0.63% |
| DAFNA Capital Management LLC | 85,947 | $615,000 | 0.43% |
| Lapides Asset Management, LLC | 326,800 | $2,340,000 | 0.40% |
| BRANDES INVESTMENT PARTNERS, LP | 3,414,913 | $24,450,000 | 0.37% |